Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107285 · ClinicalTrials.gov registry record
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy
A clinical trial of Lymphoma Receiving CAR-T Therapy, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT04107285 is a study of Lymphoma Receiving CAR-T Therapy that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04107285, a study of Lymphoma Receiving CAR-T Therapy, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (structure) and function, in people with lymphoma receiving CAR-T therapy.
Conditions Studied
Interventions
- BEHAVIORAL neurocognitive evaluations
- DIAGNOSTIC_TEST brain MRIs
- OTHER Blood samples
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04107285
The ClinicalTrials.gov registry entry for NCT04107285 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphoma Receiving CAR-T Therapy appearing as the primary indexed condition, and to 3 interventions - of which neurocognitive evaluations is the first listed.
NCT04107285 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04107285 about?
NCT04107285 is a clinical study titled "Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy". The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (structure) and function, in people with lymphoma receiving CAR-T therapy.
What is the current status of trial NCT04107285?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2019-09-25. Estimated completion is 2026-09.
What conditions does trial NCT04107285 study?
This clinical trial studies the following conditions: Lymphoma Receiving CAR-T Therapy.
What interventions are being tested in trial NCT04107285?
The interventions under investigation include: neurocognitive evaluations (BEHAVIORAL), brain MRIs (DIAGNOSTIC_TEST), Blood samples (OTHER).
Who is sponsoring clinical trial NCT04107285?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04107285 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.